NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 38 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,320 | -4.2% | 31,999 | +76.8% | 0.00% | – |
Q2 2023 | $8,688 | -86.7% | 18,100 | -81.7% | 0.00% | – |
Q1 2023 | $65,151 | -32.3% | 98,823 | +13.9% | 0.00% | – |
Q4 2022 | $96,268 | -12.5% | 86,728 | -41.4% | 0.00% | – |
Q3 2022 | $110,000 | -11.3% | 147,885 | -28.0% | 0.00% | – |
Q2 2022 | $124,000 | -80.0% | 205,374 | -18.8% | 0.00% | – |
Q1 2022 | $620,000 | -81.0% | 253,009 | -62.9% | 0.00% | – |
Q4 2021 | $3,256,000 | +6.1% | 681,712 | +106.0% | 0.00% | – |
Q3 2021 | $3,068,000 | – | 330,928 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Texas Capital Bank Wealth Management Services Inc | 63,290 | $41,714 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 230,700 | $152,054 | 0.00% |
Virtu Financial LLC | 46,210 | $30 | 0.00% |
United Asset Strategies, Inc. | 18,300 | $12,062 | 0.00% |
HBK Sorce Advisory LLC | 29,230 | $19,266 | 0.00% |
UBS Group AG | 18,611 | $12,265 | 0.00% |
NewEdge Advisors, LLC | 2,125 | $1,401 | 0.00% |
OSAIC HOLDINGS, INC. | 27,225 | $17,933 | 0.00% |
BANK OF AMERICA CORP /DE/ | 30,000 | $19,770 | 0.00% |
WELLS FARGO & COMPANY/MN | 5,309 | $3,500 | 0.00% |